Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0UOAJM
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anti-GPC2 ADC
|
|||||
| Synonyms |
Anti GPC2 ADC
Click to Show/Hide
|
|||||
| Organization |
The Children's Hospital of Philadelphia
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Neuroblastoma [ICD11:2A00]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Glypican-2 (GPC2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Y289L mutant beta4Gal-T1 enzyme was used to conjugate GalNaz to terminal biantennary N-acetylglucosamines followed by click-reaction conjugation of a DBCO-activated PBD-payload.
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.